Shattuck Labs
  • About
    • Overview
    • Our Origins
    • Mission & Vision
    • Management
    • Board of Directors
    • Advisory Board
  • Our Science
    • ARC Platform
    • GADLEN Platform
    • Posters
    • Publications
  • Pipeline
    • Clinical
    • SL-172154 SIRPα-Fc-CD40L
    • SL-279252 PD1-Fc-OX40L
    • Discovery
  • Clinical Trials
    • Overview
    • SL-172154 SIRPα-Fc-CD40L
    • SL-279252 PD1-Fc-OX40L
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Info
      • Stock Quote & Chart
      • Analyst Coverage
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • IR Resources
      • FAQS
      • Email Alerts
      • IR & Media Contact
  • Careers
    • Intro to Shattuck
    • Values
    • Benefits
    • Join Our Team
    • Current Openings
  • Contact
    • Locations
    • Contact Us

News & Events

« Previous |

Phase 1 dose escalation of an agonist redirected checkpoint (ARC) fusion protein,
SL-279252 (PD1-Fc-OX40L), in subjects with advanced solid tumors or lymphomas (NCT03894618)

  • About
  • Our Science
  • Pipeline
  • Clinical Trials
  • Investors
  • Careers
  • Contact
© 2023 Shattuck Labs, Inc | Privacy | Terms of Use
logo
  • About
    • Overview
    • Our Origins
    • Mission & Vision
    • Management
    • Board of Directors
    • Advisory Board
  • Our Science
    • ARC Platform
    • GADLEN Platform
    • Posters
    • Publications
  • Pipeline
    • Clinical
    • SL-172154 SIRPα-Fc-CD40L
    • SL-279252 PD1-Fc-OX40L
    • Discovery
  • Clinical Trials
    • Overview
    • SL-172154 SIRPα-Fc-CD40L
    • SL-279252 PD1-Fc-OX40L
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Info
      • Stock Quote & Chart
      • Analyst Coverage
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • IR Resources
      • FAQS
      • Email Alerts
      • IR & Media Contact
  • Careers
    • Intro to Shattuck
    • Values
    • Benefits
    • Join Our Team
    • Current Openings
  • Contact
    • Locations
    • Contact Us
  • Follow Us